Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation.
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
24
11
2020
received:
14
08
2020
accepted:
09
01
2021
pubmed:
13
1
2021
medline:
24
3
2022
entrez:
12
1
2021
Statut:
ppublish
Résumé
Post-transplant diabetes mellitus (PTDM) is common after solid organ transplantation (SOT) and associated with increased morbidity and mortality for allograft recipients. Despite the significant burden of disease, there is a paucity of literature with regards to detection, prevention and management. Evidence from the general population with diabetes may not be translatable to the unique context of SOT. In light of emerging clinical evidence and novel anti-diabetic agents, there is an urgent need for updated guidance and recommendations in this high-risk cohort. The Association of British Clinical Diabetologists (ABCD) and Renal Association (RA) Diabetic Kidney Disease Clinical Speciality Group has undertaken a systematic review and critical appraisal of the available evidence. Areas of focus are; (1) epidemiology, (2) pathogenesis, (3) detection, (4) management, (5) modification of immunosuppression, (6) prevention, and (7) PTDM in the non-renal setting. Evidence-graded recommendations are provided for the detection, management and prevention of PTDM, with suggested areas for future research and potential audit standards. The guidelines are endorsed by Diabetes UK, the British Transplantation Society and the Royal College of Physicians of London. The full guidelines are available freely online for the diabetes, renal and transplantation community using the link below. The aim of this review article is to introduce an abridged version of this new clinical guideline ( https://abcd.care/sites/abcd.care/files/site_uploads/Resources/Position-Papers/ABCD-RA%20PTDM%20v14.pdf).
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14523Informations de copyright
© 2021 Diabetes UK.
Références
Byrne C, Caskey F, Castledine C, et al. UK Renal Registry 20th annual report of the Renal Association. Nephron. 2018;139 (suppl 1):1-12.
Sharif A, Heckin M, de Vries APR, et al. Proceedings from an international consensus meeting on posttransplant diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14:1992-2000.
Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):SS3-24.
Arner P, Gunnarsson R, Blomdahl B, Groth CG. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care. 1983;6(1):23-25.
Sharif A, Shabir S, Chand S, Cockwell P, Ball S, Borrows R. Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. J Am Soc Nephrol. 2011;22(11):2107-2118.
McCaughan JA, Courtney AE. The clinical course of kidney transplant recipients after 20 years of graft function. Am J Transplant. 2015;15(3):734-740.
Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A. Reduced Incidence of New-Onset Post transplantation Diabetes Mellitus During the Last Decade. Transplantation. 2007;84(9):1125-1130. https://doi.org/10.1097/01.tp.0000287191.45032.38.
Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3(2):178-185.
Dienemann T, Fujii N, Li Y, et al. Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Transpl Int. 2016;29(9):1017-1028.
Eide IA, Halde TAS, Hartmann A, et al. Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria. Transpl Int. 2016;29(5):568-578.
Gaynor JJ, Ciancio G, Guerra G, et al. Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant. Diabetologia. 2015;58(2):334-345.
Eide IA, Halde TAS, Hartmann A, et al. Associations between posttransplantation diabetes mellitus and renal graft survival. Transplantation. 2017;101(6):1282-1289.
Cole EH, Johnston O, Rose C, Gill J. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol. 2008;3(3):814-821.
Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis. 2010;56(6):1127-1139.
Valderhaug TG, Hjelmesaeth J, Jenssen T, Røislien J, Leivestad T, Hartmann A. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation. 2012;94(7):714-720.
Johal S, Jackson-Spence F, Gillott H, et al. Pre-existing diabetes is a risk factor for increased rates of cellular rejection after kidney transplantation: an observational cohort study. Diabet Med. 2017;34(8):1067-1073.
Wauters RP, Cosion FG, Fernandez MLS, Kudva Y, Shah P, Torres VE. Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation. 2012;94(4):377-382.
Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496-506.
Porrini E, Díaz JM, Moreso F, et al. Prediabetes is a risk factor for cardiovascular disease following renal transplantation. Kidney Int. 2019;96(6):1374-1380.
Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 2007;83(8):1027-1034.
Londero TM, Giaretta LS, Farenzena LP, et al. Microvascular complications of posttransplant diabetes mellitus in kidney transplant recipients: a longitudinal study. J Clin Endocrinol Metab. 2019;104(2):557-567.
Sundaram H, Smith RD, Viero R, First MR. Diabetic nephropathy after renal transplantation: clinical and pathologic features. Transplantation. 1996;62:632-635.
Bhalla V, Nast CC, Stollenwerk N, et al. Recurrent and de novo diabetic nephropathy in renal allografts. Transplantation. 2003;75(1):66-71.
Cheungpasitporn W, Thongprayoon C, Vijayvargiya P, Anthanont P, Erickson SB. The risk for new-onset diabetes mellitus after kidney transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. Can J Diabetes. 2016;40(6):521-528.
Ruderman I, Masterson R, Yates C, Gorelik A, Cohney SJ, Walker RG. New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study. Nephrology. 2012;17(1):89-96.
Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4(4):583-595.
Duijnhoven EM, Boots JM, Christiaans MH, Wolffenbuttel BH, Van Hooff JP. Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study. J Am Soc Nephrol. 2001;12(3):583-588.
Tamura K, Fujimura T, Tsutsumi T, et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation. 1995;59(11):1606-1613.
Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1-13.
Porrini E, Delgado P, Alvarez A, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transplant. 2008;23(4):1436-1441.
Triñanes J, Rodriguez-Rodriguez AE, Brito-Casillas Y, et al. Deciphering tacrolimus-induced toxicity in pancreatic β cells. Am J Transplant. 2017;17(11):2829-2840.
McCaughan JA, McKnight AJ, Maxwell AP. Genetics of new-onset diabetes after transplantation. J Am Soc Nephrol. 2014;25(5):1037-1049.
Valderhaug TG, Hjelmesaeth J, Hartmann A, et al. The association of early post-transplant glucose levels with long-term mortality. Diabetologia. 2011;54(6):1341-1349.
Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130-1139.
Sharif A, Moore RH, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation. 2006;82(12):1667-1672.
Valderhaug TG, Jenssen T, Hartmann A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation. 2009;88(3):429-434.
Mollar-Puchades MA, Malek-Marin T, Merino-Torres JF, Ramos-Escorihuela D, Sánchez-Plumed J, Piñón-Sellés F. Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Invest. 2009;32(3):263-266.
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
De Marchi S, Cecchin E, Basile A, et al. More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis. Nephron. 1983;35(1):49-53.
Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126-128.
Hoban R, Gielda B, Temkit MH, et al. Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation. 2006;81(3):379-383.
Shabir S, Jham S, Harper L, Ball S, Borrows R, Sharif A. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transpl Int. 2013;26(3):315-321.
Yates CJ, Fourlanos S, Colman P, Cohney SJ. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. Transplantation. 2013;96(8):726-731.
Eide IA, Halden TAS, Hartmann A, et al. Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus. Transplantation. 2015;99(3):629-635.
Tillmann FP, Rump LC, Quack I. HbA1c levels at 90 days after renal transplantation in non-diabetic recipients predict de novo pre-diabetes and diabetes at 1 and 3 years after transplantation. Int Urol Nephrol. 2018;50(8):1529-1534.
Werzowa J, Pacini G, Hecking M, et al. Comparison of glycaemic control and variability in patients with type 2 diabetes and post-transplant diabetes mellitus after renal transplantation. J Diab Comps. 2015;29:1211-1216.
Pasti K, Prokai A, Meszaros C, et al. Continuous glucose monitoring system (CGMS) in kidney-transplanted children. Pediatr Transplant. 2013;17(5):454-460.
Rodriguez LM, Knight RJ, Heptulla RA. Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. Diabetes Technol Ther. 2010;12(5):347-351.
Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnsone RN. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. BMJ. 1983;287(6396):863-867.
Gupta S, Pollack T, Fulkerson C, et al. Hyperglycemia in the posttransplant period: NODAT vs posttransplant diabetes mellitus. J Endocr Soc. 2018;2(11):1314-1319.